Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug;11(4):369-73.
doi: 10.3109/17482960903420140.

Pattern of spread and prognosis in lower limb-onset ALS

Affiliations

Pattern of spread and prognosis in lower limb-onset ALS

Martin R Turner et al. Amyotroph Lateral Scler. 2010 Aug.

Abstract

Our objective was to establish the pattern of spread in lower limb-onset ALS (contra- versus ipsi-lateral) and its contribution to prognosis within a multivariate model. Pattern of spread was established in 109 sporadic ALS patients with lower limb-onset, prospectively recorded in Oxford and Sheffield tertiary clinics from 2001 to 2008. Survival analysis was by univariate Kaplan-Meier log-rank and multivariate Cox proportional hazards. Variables studied were time to next limb progression, site of next progression, age at symptom onset, gender, diagnostic latency and use of riluzole. Initial progression was either to the contralateral leg (76%) or ipsilateral arm (24%). Factors independently affecting survival were time to next limb progression, age at symptom onset, and diagnostic latency. Time to progression as a prognostic factor was independent of initial direction of spread. In a regression analysis of the deceased, overall survival from symptom onset approximated to two years plus the time interval for initial spread. In conclusion, rate of progression in lower limb-onset ALS is not influenced by whether initial spread is to the contralateral limb or ipsilateral arm. The time interval to this initial spread is a powerful factor in predicting overall survival, and could be used to facilitate decision-making and effective care planning.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Scatter plot of overall survival against time from onset to progression to another limb (in months) in patients with lower limb-onset ALS who had died at the time of censoring. Regression line and individual 95% confidence intervals are shown. The overall survival is approximately two years plus the time to progression.

Similar articles

Cited by

References

    1. Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79:6–11. - PubMed
    1. Turner MR, Parton MJ, Shaw CE, Leigh PN, Al Chalabi A. Prolonged survival in motor neuron disease: a descriptive study of the Kings’ database 1990–2002. J Neurol Neurosurg Psychiatry. 2003;74:995–7. - PMC - PubMed
    1. Hu MT, Ellis CM, Al Chalabi A, Leigh PN, Shaw CE. Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1998;65:950–1. - PMC - PubMed
    1. Cappellari A, Ciammola A, Silani V. The pseudopolyneuritic form of amyotrophic lateral sclerosis (Patrikios’ disease) Electromyogr Clin Neurophysiol. 2008;48:75–81. - PubMed
    1. Wijesekera LC, Mathers S, Talman P, Galtrey C, Parkinson MH, Ganesalingam J, et al. Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology. 2009;72:1087–94. - PMC - PubMed

Publication types